A preliminary experiment of absorption of antinuclear antibodies by the hepatitis B vaccine components, in a case of neurolupus

Vaccine

Volumn 22, Issue 23-24, 2004, Pages 3166-3168

  Poirriez, Jean ^a  

^a 4 10 Rue Albert Thomas 59210   (France)

Author keywords

Absorption; Antinuclear antibodies; Hepatitis B vaccine; Neurolupus

Indexed keywords

ANTINUCLEAR ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE;

ANAMNESIS; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ANTIBODY TITER; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; CHEMOLUMINESCENCE; CHILD; CLINICAL FEATURE; CONCENTRATION (PARAMETERS); DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DRUG INFUSION; FEMALE; HEPATITIS B; HUMAN; IMMUNOFLUORESCENCE TEST; LABORATORY TEST; LOW DRUG DOSE; MEDICAL EXAMINATION; MYELITIS; NEUROLOGIC EXAMINATION; PRIORITY JOURNAL; SECONDARY PREVENTION;

ABSORPTION; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; CHEMILUMINESCENT MEASUREMENTS; CHILD; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNOASSAY; NERVOUS SYSTEM DISEASES;

EID: 3843053617     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2004.01.056     Document Type: Article

References (16)

1. Koff RS. Immunologically mediated extrahepatic manifestations of viral hepatitis. In: Krawitt EL, Wiesner RH, editors. Autoimmune liver diseases. New York: Raven Press; 1991. p. 233-45.
2. Lavine JE, Bull FG, Millward-Sadler GH, Arthur MJP. Acute viral hepatitis. In: Millward-Sadler GH, Wright R, Arthur MJP, editors. Wright's liver and biliary disease. London: WB Saunders Company; 1992. p. 679-786.
3. Valla DC. Manifestations extrahépatiques des hépatites virales. In: Trépo C, Valla D, editors. Progrès en hépato-gastroentérologie. 9. Hépatites virales. Paris: Doin; 1993. p. 161-72.
4. Carmeli Y., De-Medina T. Serious hepatitis B vaccine adverse reactions: are they immune-mediated? Vaccine. 11:1993;1358-1359
5. Grotto I., Mandel Y., Ephros M., Ashkenazi I., Shemer J. Major adverse reactions to yeast-derived hepatitis B vaccine - a review. Vaccine. 16:1998;329-334
6. Cohen A.D., Shoenfeld Y. Vaccine-induced autoimmunity. J. Autoimmun. 9:1996;699-703
7. Shoenfeld Y., Aharon-Maor A., Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin. Exp. Rheumatol. 18:2000;181-184
8. Roitt IM, Brostoff J, Male DK. Immunologie fondamentale et appliquée. Paris: MEDSI; 1985.
9. Legout L., Hachulla E., Chérin P., Poiriez J., Queyrel V., Michon-Pasturel U., et al. Maladies auto-immunes et vaccination contre l'hépatite B: faut-il vacciner nos patients? Rev. Méd. Int. 22:2001;402-405
10. Goldman M., Gleason N.N. Antigenic analysis of Entamoeba histolytica by means of fluorescent antibody. IV: relationships of two strains of E. histolytica and one of E. hartmanni demonstrated by cross-absorption techniques. J. Parasitol. 48:1962;778-783
11. Jensen P., Johansen H.K., Carmi P., Hoiby N., Cohen I.R. Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis. J. Autoimmun. 17:2001;165-172
12. Kirkland JJ. Chromatographie en phase liquide. Paris: Gauthier-Villars; 1973.
13. Playfair J.H.L. Immunity to malaria. Br. Med. Bull. 38:1982;153-159
14. Poirriez J. Quelques commentaires sur la vaccination contre l'hépatite B en France. Presse Méd. 28:1999;1242-1244
15. Poirriez J. Some questions to be raised about the hepatitis B vaccine. Vaccine. 20:2002;1696-1698
16. Poirriez J. A new method for risk analysis of vaccines. Vaccine. 17:1999;2335